哈乐联合青藤碱治疗前列腺炎的临床观察

目的：观察哈乐联合青藤碱治疗前列腺炎的疗效。方法：将90例符合入选标准的前列腺患者,随机分为联合治疗组和对照组。对照组给予哈乐0．2mg;联合治疗组在此基础上给予青藤碱口服,一日3次,前期一次2片,一日3次;三日增至一次3片,一日3次。治疗4周,观察疗效和比较两组患者前列腺液中TNF-α、IL-6表达。结果：联合治疗组总有效率显著优于对照组（P〈0．05）,前列腺液中TNF-α、IL-6表达明显低于对照组。结论：哈乐配合青藤碱,能增强其对前列腺炎的疗效。     

青藤碱对慢性非细菌性大鼠前列腺炎大鼠炎症反应及P38Mapk信号通路的影响

目的:观察青藤碱对慢性非细菌性大鼠前列腺炎大鼠炎症反应及P38Mapk信号通路的影响。方法:将SD大鼠随机分为对照组、青藤碱高、低剂量组。对照组组给予生理盐水灌胃,青藤碱低、中、高剂量组分别给予青藤碱40、80、160mg/kg灌胃,28天后处死。realtime RT-PCR法和western blot法检测肿瘤组织中TNF-、IL-6 mRNA和TNF-、IL-6、p-P38 MAPK蛋白的表达。结果:青藤碱能明显降低慢性非细菌性大鼠前列腺炎大鼠前列腺组织中TNF-、IL-6 mRNA和TNF-、IL-6、p-P38 MAPK蛋白的表达。结论:青藤碱能抑制慢性非细菌性大鼠前列腺炎大鼠前列腺炎症反应,其机制可能与抑制P38 MAP信号通路有关。     

青藤碱对慢性非细菌性大鼠前列腺炎大鼠炎症反应及P38Mapk信号通路的影响

目的：观察青藤碱对慢性非细菌性大鼠前列腺炎大鼠炎症反应及P38Mapk信号通路的影响。方法：将SD大鼠随机分为对照组、青藤碱高、低剂量组。对照组组给予生理盐水灌胃,青藤碱低、中、高剂量组分别给予青藤碱40,80、160mg／kg灌胃,28天后处死。realtimeRT-PCR法和westernblot法检测肿瘤组织中TNF-、IL-6rnR_NA和TNF-、IL-6、P—P38MAPK蛋白的表达。结果：青藤碱能明显降低慢性非细菌性大鼠前列腺炎大鼠前5,1腺组织中TNF-、IL-6mRNA和TNF-、IL-6、p-P38MAPK蛋白的表达。结论：青藤碱能抑制慢性非细菌性大鼠前列腺炎大鼠前列腺炎症反应,其机制可能与抑制P38MAP信号通路有关。     

电针配合中药熏蒸对慢性前列腺炎患者疗效和前列腺液中IL-17、TNF-α水平的影响

目的:探讨电针配合中药熏蒸对慢性前列腺炎患者疗效和前列腺液中白细胞介素-17(IL-17)、肿瘤坏死因子-α(TNF-α)水平的影响。方法:选取2017年6月～2018年8月我院接收的慢性前列腺炎患者120例,根据随机数字表法分为观察组(n=60)和对照组(n=60)。对照组采用西医药物治疗,观察组采用电针配合中药熏蒸治疗。评价并比较两组疗效,比较两组患者治疗前后美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分、最大尿流率(Qmax)、平均尿流率(Qave)以及前列腺液IL-17、TNF-α水平。结果:观察组总有效率为90.00%,明显高于对照组的71.67%(P0.05)。治疗后,两组NIH-CPSI评分中的排尿症状、疼痛或不适、生活质量评分以及总分均明显降低,且观察组NIH-CPSI各维度评分及总分均低于对照组(P0.05)。治疗后,两组Qmax、Qave明显上升,且观察组Qmax、Qave明显高于对照组(P0.05)。治疗后,两组前列腺液IL-17、TNF-α水平明显降低,且与对照组比较,观察组IL-17、TNF-α水平明显更低(P0.05)。结论:电针配合中药熏蒸治疗慢性前列腺炎疗效确切,其能明显改善患者病情和尿流率,降低患者前列腺液中IL-17、TNF-α水平。     

宁泌泰胶囊联合盐酸莫西沙星治疗慢性前列腺炎患者的临床疗效及对血清TNF-α、IL-1β、M-CSF的影响

目的:探讨宁泌泰胶囊联合盐酸莫西沙星治疗慢性前列腺炎患者的临床疗效及对血清肿瘤坏死因子(TNF)-α、白介素(IL)-1β、巨噬细胞集落刺激因子(M-CSF)水平的影响。方法:选择2014年8月至2016年8月我院接诊的110例慢性前列腺炎患者,通过随机数表法分为观察组(n=55)和对照组(n=55)。对照组采用盐酸莫西沙星治疗,观察组联合宁泌泰胶囊治疗,均连续治疗2周。比较两组治疗前后慢性前列腺炎症状评分(NIH-CPSI)、前列腺液白细胞计数、血清TNF-α、IL-1β、M-CSF水平的变化及临床疗效。结果:治疗后,观察组临床疗效总有效率明显高于对照组(P0.05);两组NIH-CPSI评分、白细胞计数、血清TNF-α、IL-1β、M-CSF均较治疗前显著降低(P0.05),观察组以上指标均明显低于对照组(P0.05)。结论:宁泌泰胶囊联合盐酸莫西沙星治疗慢性前列腺炎的临床效果显著,可有效缓解临床症状,安全性高,其机制可能和降低血清TNF-α、IL-1β、M-CSF水平相关。     

前列解毒活血汤对Ⅲ型前列腺炎患者前列腺液中细胞因子水平的影响*

目的: 探讨前列解毒活血汤对Ⅲ型前列腺炎患者前列腺液(EPS)中肿瘤坏死因子(TNF-α)、白介素-6(IL-6)及白介素-8(IL-8)的影响。方法: 将60例病患随机分成两组,即治疗组30例病患,对照组30例病患。治疗组患者每日早、晚饭后30 min温服150 ml前列解毒活血汤,对照组患者睡前30 min服用0.2 mg盐酸坦索罗辛缓释胶囊(哈乐),每日一次;另外选择30例健康男性作为空白组,不予任何处理。治疗周期为4周。治疗组、对照组患者干预前、后均要取EPS;空白组受试者只在临床干预实验进行前取一次EPS。酶联免疫吸附试验(ELISA)测定EPS中TNF-α、IL-6及IL-8含量或水平。结果: 实验开始前,治疗组、对照组患者观察值比较无差异,但与空白组比,数值显著升高(P＜0.01)。经有效干预后,治疗组、对照组患者的观察值均下降,治疗组下降趋势优于对照组(P＜0.01)。结论: 前列解毒活血汤能有效降低Ⅲ型前列腺炎患者EPS中TNF-α、IL-6及IL-8水平。     

白芍总苷联合特拉唑嗪治疗非细菌性前列腺炎临床观察

目的:探讨白芍总苷联合特拉唑嗪治疗慢性非细菌性前列腺炎的临床效果.方法:将138例慢性非细菌性前列腺炎患者平均分为观察组和对照组,分别给予特拉唑嗪(2mg,每晚1次)+白芍总苷(0.6g,每天3次)和特拉唑嗪(2mg,每晚1次)治疗,12周后观察临床总体疗效、慢性前列腺炎症状指数(NIH-CPSI)评分及前列腺液常规.结果:观察组和时照组的临床总有效率、NIH-CPSI评分及前列腺液WBC计数均有显著改善,但观察组的改善程度均优于对照组.结论:白芍总苷联合特拉唑嗪治疗慢性非细菌性前列腺炎较单用特拉唑嗪疗效明显,值得临床推广.     

温针联合骨疏康胶囊治疗膝关节骨性关节炎的疗效及对炎症因子的影响

目的:分析温针联合骨疏康胶囊治疗膝关节骨性关节炎的疗效及对患者白细胞介素-1(IL-1)、肿瘤坏死因子(TNF-α)、基质金属蛋白(MMP-3)水平的影响。方法:以2013年1月至2016年1月新疆巴音郭楞蒙古自治州人民医院中医科收治的90例膝关节骨性关节炎患者为研究对象,并根据就诊顺序分为观察组、对照组A和对照组B,每组30例。观察组采用温针联合骨疏康胶囊治疗,对照组A仅给予温针治疗,对照组B仅给予骨疏康胶囊治疗。观察和比较三组的临床疗效、视觉模拟评分法(VAS)评分、Lysholm膝关节康复量表(LKSS)评分和症状评分及膝关节液中IL-1、TNF-α、MMP-3水平。结果:观察组的总有效显著高于对照组A和对照组B(P0.05),而对照组A和对照组B之间比较差异无统计学意义(P0.05)。治疗后,三组的VAS、症状评分、膝关节液中IL-1、TNF-α、MMP-3水平均较治疗前显著降低,LKSS评分较治疗前显著升高(P0.05)。观察组的VAS、症状评分、膝关节液中IL-1、TNF-α、MMP-3水平低于对照组A和对照组B,LKSS评分高于对照组A和对照组B(P0.05),对照组A和对照组B之间比较差异均无统计学意义(P0.05)。结论:温针联合骨疏康胶囊治疗膝关节骨性关节炎的疗效较单用温针或骨疏康胶囊更显著,可有效改善患者的临床症状,可能与降低膝关节液中IL-1、TNF-α、MMP-3水平有关。     

纳洛酮联合依达拉奉治疗重症脑梗死的临床疗效及对血浆TNF-α及IL-6水平的影响

目的:探讨纳洛酮联合依达拉奉治疗重症脑梗死的临床疗效及对血浆肿瘤坏死因子(TNF)-α、白介素(IL-6)水平的影响。方法:选择2014年10月至2016年10月我院接诊的92例重症脑梗死患者,通过随机数表法分为观察组(n=46)和对照组(n=46)。两组均给予降脂、控制血糖、血压、降颅压、维持水电解质、营养脑细胞等常规治疗。对照组在此基础上给予依达拉奉的静脉滴注,剂量30 mg,2次/d;观察组在对照组的基础上给予纳洛酮的静脉滴注,剂量2 mg,1次/d,均连续治疗14 d。比较两组临床疗效及治疗前后血浆TNF-α、IL-6、NIHSS评分、Barthel指数的变化以及不良反应的发生情况。结果:治疗14d后,观察组临床疗效总有效率明显高于对照组(P0.05)。与治疗前比较,两组治疗后血浆TNF-α、IL-6水平、NIHSS评分均显著下降(P0.05),Barthel指数明显上升(P0.05),且观察组血浆TNF-α、IL-6水平、NIHSS评分均明显低于对照组(P0.05),Barthel指数显著高于对照组(P0.05)。两组治疗过程中均未有严重不良反应发生。结论:纳洛酮联合依达拉奉治疗重症脑梗死患者的临床效果显著,可促进神经功能恢复,且安全性高,可能与其有效降低血浆血浆TNF-α、IL-6水平有关。     

苯磺酸左旋氨氯地平片联合厄贝沙坦对老年难治性高血压的临床疗效

目的:探讨苯磺酸左旋氨氯地平片与厄贝沙坦的联合应用对老年难治性高血压患者临床疗效的影响及其可能机制。方法:选取我院确诊并治疗的老年难治性高血压患者72例作受试者,按随机数字表法分为两组,对照组36例予以利尿药联合厄贝沙坦进行血压调控,治疗组36例在对照组基础上予联合苯磺酸左旋氨氯地平片2.5 mg日一次进行治疗。观察两组患者的临床疗效,监控患者血压情况,比较治疗前后患者血清同型半胱氨酸(Hcy)、TNF-α及IL-6水平的变化。结果:对照组总有效率低于治疗组(P0.05);与对照组比较,治疗组患者血压控制情况较好,治疗后血清Hcy、TNF-α及IL-6水平降低,差异具有统计学意义(P0.05)。结论:苯磺酸左旋氨氯地平片与厄贝沙坦的联合应用可有效控制老年难治性高血压患者的血压、尽早恢复患者血压稳定,可能与其降低血清Hcy、TNF-α、IL-6的水平有关。     

Investigation of the mechanism of temperature sensitivity of the electroreceptors of ampullae of lorenzini

In experiments on Black Sea skates (Raja clavata), the potential of the receptor epithelium of the ampullae of Lorenzini and spike activity of single nerve fibers connected to them were investigated during electrical and temperature stimulation. Usually the potential within the canal was between 0 and –2 mV, and the input resistance of the ampulla 250–400 k. Heating of the region of the receptor epithelium was accompanied by a negative wave of potential, an increase in input resistance, and inhibition of spike activity. With worsening of the animal's condition the transepithelial potential became positive (up to +10 mV) but the input resistance of the ampulla during stimulation with a positive current was nonlinear in some cases: a regenerative spike of positive polarity appeared in the channel. During heating, the spike response was sometimes reversed in sign. It is suggested that fluctuations of the transepithelial potential and spike responses to temperature stimulation reflect changes in the potential difference on the basal membrane of the receptor cells, which is described by a relationship of the Nernst's or Goldman's equation type.I. P. Pavlov Institute of Physiology, Academy of Sciences of the USSR, Leningrad. I. M. Sechenov, Institute of Evolutionary Physiology and Biochemistry, Academy of Sciences of the USSR, Leningrad. Pacific Institute of Oceanology, Far Eastern Scientific Center, Academy of Sciences of the USSR, Vladivostok. Translated from Neirofiziologiya, Vol. 12, No. 1, pp. 67–74, January–February, 1980.     

Principles of organization and evolution of systems of regulation of functions

Evolution of living organisms is closely connected with evolution of structure of the system of regulations and its mechanisms. The functional ground of regulations is chemical signalization. As early as in unicellular organisms there is a set of signal mechanisms providing their life activity and orientation in space and time. Subsequent evolution of ways of chemical signalization followed the way of development of delivery pathways of chemical signal and development of mechanisms of its regulation. The mechanism of chemical regulation of the signal interaction is discussed by the example of the specialized system of transduction of signal from neuron to neuron, of effect of hormone on the epithelial cell and modulation of this effect. These mechanisms are considered as the most important ways of the fine and precise adaptation of chemical signalization underlying functioning of physiological systems and organs of the living organism